MCP 3 Human

Monocyte Chemotactic Protein-3 Human Recombinant (CCL7)
Shipped with Ice Packs
In Stock

Description

Introduction to MCP-3 (CCL7)

Monocyte Chemotactic Protein-3 (MCP-3/CCL7) is a 9 kDa chemokine belonging to the CC-chemokine subfamily. Structurally, it consists of 76 amino acids and shares 71% sequence homology with MCP-1 and 58% with MCP-2 . Produced by macrophages, dendritic cells, and tumor cell lines, MCP-3 signals through G protein-coupled receptors CCR1, CCR2, and CCR3, enabling its role in immune cell recruitment and inflammation . Unlike other MCPs, it exhibits broad cellular activation, targeting monocytes, neutrophils, eosinophils, basophils, and natural killer cells .

Biological Functions and Mechanisms of Action

MCP-3 regulates immune responses through:

  • Chemotaxis: Directs migration of monocytes, lymphocytes, and dendritic cells to inflammation sites .

  • Cytokine storm modulation: Elevated levels correlate with severe viral infections (e.g., SFTS, COVID-19), driving hyperinflammation .

  • Tumor microenvironment interaction: Promotes macrophage infiltration in cancers, potentially aiding metastasis via protease secretion .

Receptor specificity:

ReceptorBinding AffinityTarget Cells
CCR1HighMonocytes, NK cells
CCR2ModerateMonocytes, T cells
CCR3ModerateEosinophils, basophils
Data synthesized from .

Biomarker Potential

  • SFTS prognosis: Serum MCP-3 >10.89 pg/ml predicts fatal outcomes with 88.2% AUC (P <0.001) .

  • COVID-19 severity: Elevated MCP-3 and IP-10 levels correlate with critical illness (AUC=0.99 when combined) .

  • Inflammatory diseases: Linked to Crohn’s disease, ulcerative colitis, and multiple sclerosis .

Comparative clinical studies:

DiseaseMCP-3 RoleStudy DesignKey Finding
SFTSPrognostic biomarker78 patients, ROC analysis65.2% fatality in high-MCP-3 group
COVID-19Severity indicator136 patients, cytokine panelPredicts progression to critical stage
OsteosarcomaTumor microenvironment modulatorIn vitro MG-63 cell studyStimulates gelatinase B secretion

Emerging Research and Future Directions

  • Mechanistic studies: Current gaps in understanding MCP-3’s role in SFTS pathogenesis necessitate in vivo models .

  • Therapeutic targeting: CCR2/CCR3 inhibition is being explored to mitigate cytokine storms in viral infections .

  • Diagnostic tools: Quanterix’s Simoa® MCP-3 Discovery Kit achieves detection limits of 0.124 pg/mL, enhancing clinical utility .

Product Specs

Introduction
Chemokine (C-C motif) ligand 7, also known as CCL7, is a small cytokine belonging to the chemokine family. Previously referred to as monocyte-specific chemokine 3 (MCP3), CCL7 is classified as a CC chemokine due to the presence of two adjacent N-terminal cysteine residues in its mature protein structure. This chemokine exhibits a specific attraction towards monocytes and plays a role in regulating macrophage function. Production of CCL7 is observed in specific tumor cell lines and macrophages. In humans, the gene encoding this chemokine is located on chromosome 17 within a large cluster that also contains numerous other CC chemokines. Notably, CCL7 shares a close relationship with CCL2, formerly known as MCP1.
Description
Recombinant Human Monocyte Chemotactic Protein-3, produced in E. coli, is a non-glycosylated polypeptide chain consisting of 76 amino acids. With a molecular mass of 9011 Daltons, this protein is purified using proprietary chromatographic techniques.
Physical Appearance
White, lyophilized powder, sterile-filtered.
Formulation
The protein was lyophilized from a sterile solution at a concentration of 1 mg/ml, without the addition of any additives.
Solubility
For reconstitution of the lyophilized Monocyte Chemotactic Protein-3, it is recommended to use sterile 18 MΩ-cm H2O at a minimum concentration of 100 µg/ml. Further dilutions can be prepared using other aqueous solutions.
Stability
Lyophilized MCP-3 remains stable at room temperature for a period of 3 weeks. However, it is advisable to store it in a desiccated state below -18°C. After reconstitution, CCL7 should be stored at 4°C for 2-7 days. For long-term storage, it is recommended to store it below -18°C after adding a carrier protein such as 0.1% HSA or BSA. Avoid repeated freeze-thaw cycles.
Purity
The purity is determined to be greater than 98.0% through the following analyses: (a) RP-HPLC analysis (b) SDS-PAGE analysis
Biological Activity
The specific activity of MCP-3 is assessed by its capacity to chemoattract human peripheral blood. This activity is observed at concentrations ranging from 8 to 80 ng/ml, corresponding to a specific activity of 12,500-125,000 IU/mg.
Synonyms
Small inducible cytokine A7, CCL7, Monocyte chemotactic protein 3, MCP-3, Monocyte chemoattractant protein 3, NC28, chemokine (C-C motif) ligand 7, FIC, MARC, MCP3, SCYA6, SCYA7, MGC138463, MGC138465.
Source
Escherichia Coli.
Amino Acid Sequence
The sequence of the first five N-terminal amino acids was determined and was found to be Gln-Pro-Val-Gly-Ile.

Product Science Overview

Structure and Classification

CCL7 belongs to the subfamily of chemokines known as CC chemokines, characterized by having two adjacent N-terminal cysteine residues in their mature form . The human CCL7 protein consists of 76 amino acids and has a molecular weight of approximately 9 kDa . It is a non-glycosylated protein .

Genetic Location

The gene encoding CCL7 is located on chromosome 17 in humans, within a large cluster containing many other CC chemokines . CCL7 shares significant sequence identity with other monocyte chemotactic proteins, such as MCP-1 and MCP-2 .

Receptors and Signaling

CCL7 signals through three different G protein-coupled receptors: CCR1, CCR2, and CCR3 . These receptors are involved in various immune responses, including the chemoattraction of monocytes, which are a type of white blood cell crucial for immune defense .

Biological Activity

The primary function of CCL7 is to attract monocytes to sites of inflammation or injury, where they can differentiate into macrophages and dendritic cells . This process is essential for the immune system’s ability to respond to infections and tissue damage . The biological activity of CCL7 is typically measured by its ability to chemoattract human neutrophils .

Applications and Stability

Recombinant human MCP-3 is used extensively in research to study its role in immune responses and its potential therapeutic applications . The protein is typically produced in Escherichia coli (E. coli) and is available in a lyophilized (freeze-dried) form . For long-term storage, it is recommended to keep the lyophilized product at -20°C and reconstituted material should be aliquoted and frozen at -20°C with a carrier protein such as human serum albumin (HSA) or bovine serum albumin (BSA) to ensure stability .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.